Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We audited the accuracy of the Systemic Anti-Cancer Therapy dataset as a resource for rapid analysis of outcomes for patients, in this example, receiving Cancer Drug Fund funded monoclonal antibodies to treat metastatic colorectal cancer. We concluded that the Systemic Anti-Cancer Therapy dataset is a potentially valuable resource for rapidly determining survival outcome for patients treated with chemotherapy.

Original publication

DOI

10.1016/j.clon.2017.02.011

Type

Journal article

Journal

Clin Oncol (R Coll Radiol)

Publication Date

07/2017

Volume

29

Pages

e134 - e136

Keywords

CDF, Cancer Drug Fund, SACT, Systemic Anti-Cancer Therapy dataset, cetuximab, colorectal, Antineoplastic Agents, Cetuximab, Colorectal Neoplasms, Female, Humans, Male, Treatment Outcome